Loma Linda University Health announces study of combination monoclonal antibody treatment for early COVID-19

Loma Linda University Health announces study of combination monoclonal antibody treatment for early COVID-19
Loma Linda University Health announced on Feb. 10 the phase 2 study of the combination of the two monoclonal antibodies BRII-196 and BRII-198 for the treatment of non-hospitalized individuals with ear……

Black summer . . . one year on.

Black summer . . . one year on.
We were burnt out on New Year’s Eve,” says Bill. “It’s had a fair impact on our property.” It has been one year since the 2019-2020 bushfire season ravaged the Australian landscape. Known as the “Blac……